Brief: Allergy Therapeutics Announces Satisfaction Of FDI Clearance Conditions
Sept 22 (Reuters) - Allergy Therapeutics PLC AGY.L :
* ALLERGY THERAPEUTICS - SATISFACTION OF FDI CLEARANCE
CONDITIONS
* ALLERGY THERAPEUTICS - ALL FDI CLEARANCE CONDITIONS HAVE
BEEN
SATISFIED IN RELATION TO EQUITY FINANCING PREVIOUSLY ANNOUNCED
* ALLERGY THERAPEUTICS PLC - EQUITY FINANCING WILL RAISE
GROSS
PROCEEDS OF £40.75 MILLION
Source text for Eikon: ID:nRSV2874Na
Further company coverage: AGY.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Allergy Therapeutics
See all newsBrief: Allergy Therapeutics Expects FY 2026 Revenue Of £59.90 Million, Up 9% Reported
UK's Allergy Therapeutics FY revenue beats on Grassmuno launch
Allergy Therapeutics - Trading update for the year ended 30 June 2026
Brief: Allergy Therapeutics Appoints Helge Weiner-Trapness As Executive Chairman
Allergy Therapeutics - Appointment of Executive Chairman